| 83 | 2 | 64 |
| 下载次数 | 被引频次 | 阅读次数 |
目的 探讨血清C反应蛋白/白蛋白比值(CAR)及嗜酸性粒细胞/淋巴细胞比值(ELR)与慢性阻塞性肺疾病急性加重(AECOPD)合并肺部感染患者预后的相关性。方法 2019年1月-2022年6月募集180例AECOPD患者,依据是否合并肺部感染将180例AECOPD患者分为感染组(105例)和非感染组(75例),105例感染组患者依据入院治疗后预后情况,分为预后良好组(62例)和预后不良组(43例)。检测所有受试者的血清CAR和ELR水平,Logistic回归模型分析影响AECOPD合并肺部感染患者预后的危险因素,绘制ROC曲线分析CAR、ELR单独和联合检测对AECOPD合并肺部感染患者预后的影响。结果 与非感染组相比,感染组患者血清CAR(t=45.25,P<0.001)、ELR(t=20.11,P<0.001)水平升高。与预后良好组相比,预后不良组患者血清CAR、ELR水平升高(均P<0.05),且患者年龄较大、病程较长、合并肺心病比例、无创呼吸机治疗比例高,FEV1、FEV1/FVC、FVC水平低(P<0.05)。Logistic结果显示,病程、无创呼吸机治疗、CAR、ELR是影响AECOPD合并肺部感染患者预后不良的独立危险因素。ROC结果显示,血清CAR、ELR单独预测AECOPD合并肺部感染患者预后的AUC为0.778、0.787,二者联合预测的AUC为0.875,二者联合检测的AUC显著大于CAR、ELR单独检测(Z=2.128,3.236,P<0.05)。结论 AECOPD合并肺部感染患者血清CAR、ELR水平升高,二者联合检测能提高对AECOPD合并肺部感染患者预后评估的水平。
Abstract:Objective To explore the predictive value of C-reactive protein to albumin ratio(CAR) and eosinophil to lymphocyte ratio(ELR) for the prognosis of the patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD)complicated with pulmonary infection. Methods From January 2019 to June 2022, 180 AECOPD patients were recruited. Based on the presence of pulmonary infection, the 180 AECOPD patients were divided into infection group(105 cases) and non-infection group(75 cases). Among the infection group, 105 patients were further categorized into good prognosis group(62 cases) and poor prognosis group(43 cases) based on their prognosis after hospitalization. The serum CAR and ELR levels of all subjects were measured, and Logistic regression analysis was conducted to identify the risk factors influencing the prognosis of AECOPD patients with pulmonary infection. ROC curve analysis was performed to assess the predictive value of CAR and ELR, both individually and in combination, for the prognosis of AECOPD patients with pulmonary infection. Results Compared with non-infected group, the serum levels of CAR(t=45.25, P<0.001) and ELR(t=20.11, P<0.001) in infected group patients were increased. Compared with good prognosis group, the serum levels of CAR and ELR in the poor prognosis group patients were increased(all P<0.05), and the patients had higher age, longer course, higher proportion of combined pulmonary heart disease and non-invasive ventilator treatment, as well as lower levels of FEV1, FEV1/FVC and FVC(P<0.05). The Logistic results showed that the course, non-invasive ventilator treatment, CAR and ELR were independent risk factors affecting the poor prognosis of AECOPD patients with pulmonary infection. The ROC results showed that the AUC for serum CAR and ELR separately predicting the prognosis of AECOPD patients with pulmonary infection was 0.778 and 0.787, respectively, and the AUC for their combined prediction was 0.875, significantly greater than the AUC for CAR and ELR separately(Z=2.128, 3.236, P<0.05). Conclusion The serum levels of CAR and ELR in AECOPD patients with pulmonary infection were increased, and their combined detection can improve the level of prognosis evaluation for AECOPD patients with pulmonary infection.
[1] RITCHIE A I,WEDZICHA J A.Definition,causes,pathogenesis,and consequences of chronic obstructive pulmonary disease exacerbations[J].Clin Chest Med,2020,41(3):421-438.
[2] YANG I A,JENKINS C R,SALVI S S.Chronic obstructive pulmonary disease in never-smokers:risk factors,pathogenesis,and implications for prevention and treatment[J].Lancet Respir Med,2022,10(5):497-511.
[3] 慢性阻塞性肺疾病急性加重抗感染治疗中国专家共识编写组.慢性阻塞性肺疾病急性加重抗感染治疗中国专家共识[J].国际呼吸杂志,2019,39(17):1281-1296.
[4] LONCAR Y,TARTRAT N,LASTENNET D,et al.Pulmonary infection after hepatic resection:associated factors and impact on outcomes[J].Clin Res Hepatol Gastroenterol,2022,46(4):101733.
[5] NIU Y,XING Y,LI J,et al.Effect of community-acquired pneumonia on acute exacerbation of chronic obstructive pulmonary disease[J].COPD,2021,18(4):417-424.
[6] 黄兰花,李少杰,邹莹.C反应蛋白与白蛋白比值对预测慢性阻塞性肺疾病急性加重期患者预后的价值[J].国际呼吸杂志,2017,37(23):1778-1783.
[7] GAO J,CHEN B,WU S,et al.Blood cell for the differentiation of airway inflammatory phenotypes in COPD exacerbations[J].BMC Pulm Med,2020,20(1):50.
[8] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中国医学前沿杂志(电子版),2014,6(2):67-79,80.
[9] 龙借帆,李翠,高元标,等.联合检测血清SIRT1和CTRP5水平对慢性阻塞性肺疾病急性加重期患者预后的预测价值研究[J].现代检验医学杂志,2022,37(3):162-166,176.
[10] 周燕,卢保强,黄玉龙,等.TLR7多态性及血清TLR7/IL-23/IL-17变化与COPD合并肺部感染的关联[J].中华医院感染学杂志,2022,32(4):506-510.
[11] 王娜,赵艳茹,肖鹏云.自拟活血清肺方对慢性阻塞性肺疾病患者C反应蛋白水平及肺功能的影响[J].中国现代医学杂志,2021,31(3):42-47.
[12] 陈星如,王导新.单核细胞趋化因子-1联合C反应蛋白对慢性阻塞性肺疾病合并社区获得性肺炎的诊断价值研究[J].中国实用内科杂志,2021,41(12):1056-1060.
[13] 杨晓芸,李涛,任英杰.中重度慢性阻塞性肺疾病稳定期患者C反应蛋白与肺功能急性加重次数的相关性研究[J].山西医药杂志,2019,48(3):68-70.
[14] 王玉,黄栋,梁宗安.降钙素原与白蛋白比值对急性呼吸窘迫综合征患者预后的预测价值[J].中国呼吸与危重监护杂志,2020,19(3):240-245.
[15] 廖琦,孙斐,代诗琼.老年COPD伴呼吸衰竭病人血清CHE、白蛋白、β2-MG、Cys C水平及意义[J].实用老年医学,2019,33(4):351-354.
[16] 刘京鹤,常宇飞,王建愉,等.COPD合并呼吸衰竭患者血清胆碱酯酶、前白蛋白水平及与预后的关系[J].医学研究杂志,2019,48(8):158-161.
[17] 李兰,吴彩军,李莉.关注C反应蛋白与白蛋白比值改善急危重症预后[J].中国急救医学,2023,43(6):491-496.
[18] 孙岩,祁露萱,李丰,等.血清C反应蛋白与白蛋白比值对支气管扩张症急性加重的预测价值[J].实用医学杂志,2021,37(23):2998-3002.
[19] 唐平平,洪永青,高新怀,等.稳定期慢性阻塞性肺病患者血嗜酸性粒细胞水平与炎症表型相关性研究[J].现代生物医学进展,2021,21(10):1968-1971.
[20] 王红梅,刘耘充,郑丹蕾,等.血嗜酸性粒细胞作为生物标志物在慢性阻塞性肺疾病中的研究进展[J].中华全科医学,2020,18(5):815-820.
[21] 李亚洲,辛灵艳.哮喘-慢阻肺重叠综合征患者外周血嗜酸性粒细胞水平及其与气道炎症反应、免疫抑制的关系[J].山东医药,2022,62(5):56-59.
[22] 熊慧,张鹏,潘群,等.老年冠心病PCI术后肺部感染影响因素及血CD4+T淋巴细胞水平[J].中华医院感染学杂志,2020,30(22):3457-3461.
[23] 张明,陈晓玉.系统免疫炎性指数嗜酸性粒细胞-淋巴细胞比率与乳腺癌病理特征的相关性分析[J].山西医药杂志,2022,51(2):194-197.
基本信息:
中图分类号:R563
引用信息:
[1]刘宁,焦帅,唐飞.血清CAR及ELR与AECOPD合并肺部感染患者预后的相关性研究[J].新疆医科大学学报,2024,47(09):1231-1236.
基金信息:
安徽省卫生健康科研项目(AHWJ2022b033)
2024-09-15
2024-09-15